Showing results (1-10 of 108) with videos related to
Sort By:
Pageof 11
Expert Opinion on Drug Safety|December 11, 2020
Tafenoquine: a toxicity overviewCindy S Chu, Jimee HwangFrontiers in Pharmacology|April 1, 2021
G6PD Variants and Haemolytic Sensitivity to Primaquine and Other DrugsGermana Bancone, Cindy S ChuExpert Review of Anti-Infective Therapy|August 18, 2016
Management of relapsing Plasmodium vivax malariaCindy S Chu, Nicholas J WhitePlos Medicine|April 23, 2021
The prevention and treatment of Plasmodium vivax malariaCindy S Chu, Nicholas J WhiteJournal of Travel Medicine|April 4, 2019
Tafenoquine and G6PD: a primer for cliniciansCindy S Chu, David O FreedmanMalaria Journal|February 13, 2021
Genetic polymorphisms of Plasmodium falciparum isolates from Melka-Werer, North East Ethiopia based on the merozoite surface protein-2 (msp-2) gene as a molecular markerHussein Mohammed, Ashenafi Assefa, Melkie Chernet, et al.British Journal of Clinical Pharmacology|November 8, 2025
Quantification of cure for pharmacodynamic models of antimalarial drugs: Deterministic versus stochastic approachesMeg K Tully, Robert J Commons, Julie A Simpson, et al.Internal Medicine Journal|December 6, 2018
Risk factors for mortality in patients with diabetic foot infections: a prospective cohort studySarah A Lynar, Claire H Robinson, Craig S Boutlis, et al.Malaria Journal|October 26, 2018
Genetic diversity of the msp-1, msp-2, and glurp genes of Plasmodium falciparum isolates in Northwest EthiopiaHussein Mohammed, Moges Kassa, Kalkidan Mekete, et al.The Medical Journal of Australia|March 22, 2012
Twenty-six years of enteric fever in Australia: an epidemiological analysis of antibiotic resistanceRobert J Commons, Emma McBryde, Mary Valcanis, et al.Pageof 11